pCXLE-dCas9VP192-T2A-EGFP Citations (2)

Originally described in: Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.
Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T Stem Cell Reports. 2015 Sep 8;5(3):448-59. doi: 10.1016/j.stemcr.2015.08.001. PubMed Journal

---

Articles Citing pCXLE-dCas9VP192-T2A-EGFP

Articles
Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells. Haenfler JM, Skariah G, Rodriguez CM, Monteiro da Rocha A, Parent JM, Smith GD, Todd PK. Front Mol Neurosci. 2018 Aug 15;11:282. doi: 10.3389/fnmol.2018.00282. eCollection 2018. PubMed
Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells. Javaid N, Pham TLH, Choi S. Int J Mol Sci. 2021 Jan 1;22(1). pii: ijms22010397. doi: 10.3390/ijms22010397. PubMed

If you have published an article using this material, please email us at to have your article added to this page.